349 related articles for article (PubMed ID: 21712490)
41. The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients.
Jorgenson MR; Descourouez JL; Lyu B; Astor BC; Garg N; Smith JA; Mandelbrot DA
Clin Transplant; 2019 Aug; 33(8):e13636. PubMed ID: 31194887
[TBL] [Abstract][Full Text] [Related]
42. Long-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies.
Erdbrügger U; Scheffner I; Mengel M; Schwarz A; Haller H; Gwinner W
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F925-32. PubMed ID: 26354882
[TBL] [Abstract][Full Text] [Related]
43. Detection of cytomegalovirus and human herpesvirus-6 DNA in liver biopsy specimens and their correlation with rejection after liver transplantation.
Guardia-Silva AC; Stucchi RS; Sampaio AM; Milan A; Costa SC; Boin IF
Transplant Proc; 2012 Oct; 44(8):2441-4. PubMed ID: 23026615
[TBL] [Abstract][Full Text] [Related]
44. Spectrum of cytomegalovirus-induced renal pathology in renal allograft recipients.
Rane S; Nada R; Minz M; Sakhuja V; Joshi K
Transplant Proc; 2012 Apr; 44(3):713-6. PubMed ID: 22483475
[TBL] [Abstract][Full Text] [Related]
45. Do intraoperative hemodynamic factors of the recipient influence renal graft function?
Campos L; Parada B; Furriel F; Castelo D; Moreira P; Mota A
Transplant Proc; 2012; 44(6):1800-3. PubMed ID: 22841277
[TBL] [Abstract][Full Text] [Related]
46. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.
Lee YM; Kim YH; Han DJ; Park SK; Park JS; Sung H; Hong HL; Kim T; Kim SH; Choi SH; Kim YS; Woo JH; Lee SO
Transpl Infect Dis; 2014 Jun; 16(3):397-402. PubMed ID: 24810355
[TBL] [Abstract][Full Text] [Related]
47. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
[TBL] [Abstract][Full Text] [Related]
48. Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.
Werzowa J; Schwaiger B; Hecking M; Strassl R; Schmaldienst S; Böhmig GA; Genser B; Säemann MD
Clin Transplant; 2015 Dec; 29(12):1230-8. PubMed ID: 26458731
[TBL] [Abstract][Full Text] [Related]
49. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
50. Renal transplantation in allografts with multiple versus single renal arteries.
Kamali K; Abbasi MA; Ani A; Zargar MA; Shahrokh H
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):246-50. PubMed ID: 22382214
[TBL] [Abstract][Full Text] [Related]
51. Repeat true surveillance biopsies in kidney transplantation.
Buchmann TN; Wolff T; Bachmann A; Guerke L; Steiger J; Mihatsch MJ; Dickenmann M
Transplantation; 2012 May; 93(9):908-13. PubMed ID: 22538451
[TBL] [Abstract][Full Text] [Related]
52. Delayed graft function is not associated with an increased incidence of renal allograft rejection.
Hirt-Minkowski P; Amico P; Hönger G; Praehauser C; Steiger J; Koller MT; Gürke L; Mayr M; Schaub S
Clin Transplant; 2012; 26(6):E624-33. PubMed ID: 23106785
[TBL] [Abstract][Full Text] [Related]
53. Differential diagnosis of acute allograft rejection and CMV-infection in renal transplantation by urinary cytology.
Winkelmann M; Grabensee B; Pfitzer P
Pathol Res Pract; 1985 Aug; 180(2):161-8. PubMed ID: 2997762
[TBL] [Abstract][Full Text] [Related]
54. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
[TBL] [Abstract][Full Text] [Related]
55. Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection.
McLaughlin K; Wu C; Fick G; Muirhead N; Hollomby D; Jevnikar A
Transplantation; 2002 Sep; 74(6):813-6. PubMed ID: 12364861
[TBL] [Abstract][Full Text] [Related]
56. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
Schachtner T; Stein M; Reinke P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
[TBL] [Abstract][Full Text] [Related]
57. Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation.
Bischof N; Wehmeier C; Dickenmann M; Hirt-Minkowski P; Amico P; Steiger J; Naegele K; Hirsch HH; Schaub S
Nephrol Dial Transplant; 2020 Feb; 35(2):346-356. PubMed ID: 31943075
[TBL] [Abstract][Full Text] [Related]
58. [Nephro-angiosclerosis in the graft: impact on graft survival. Study of 33 cases].
Bernadet-Monrozies P; Rostaing L; Modesto A; Cisterne JM; Durand D; Suc JM
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1153-7. PubMed ID: 8572864
[TBL] [Abstract][Full Text] [Related]
59. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
[TBL] [Abstract][Full Text] [Related]
60. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
